mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.1 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.1 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |